We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Watts Water Technologies
WTS
$11.6B
| $5.28M | 0.02% |
37,834
| – | – |
|
602
Celldex Therapeutics
CLDX
$3.04B
| $5.28M | 0.02% |
154,923
-3,999
| -3% | -$128K |
|
603
Magna International
MGA
$17.1B
| $5.27M | 0.02% |
81,895
-33,293
| -29% | -$2.47M |
|
604
StoneCo
STNE
$2.24B
| $5.26M | 0.01% |
449,485
+81,734
| +22% | +$1.07M |
|
605
The Bancorp
TBBK
$2.07B
| $5.18M | 0.01% |
+183,006
| New | +$5.27M |
|
|
SRC
606
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $5.18M | 0.01% |
+112,518
| New | +$5.24M |
|
607
TTEC Holdings
TTEC
$59.6M
| $5.17M | 0.01% |
62,600
-13,800
| -18% | -$1.11M |
|
608
Enphase Energy
ENPH
$4.7B
| $5.17M | 0.01% |
25,600
-12,300
| -32% | -$1.93M |
|
609
Synaptics
SYNA
$3.49B
| $5.15M | 0.01% |
+25,800
| New | +$5.72M |
|
|
EVBG
610
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $5.02M | 0.01% |
115,038
-371,553
| -76% | -$17.6M |
|
611
iQIYI
IQ
$1.04B
| $5.02M | 0.01% |
1,105,684
+97,738
| +10% | +$408K |
|
612
ConocoPhillips
COP
$159B
| $4.99M | 0.01% |
49,872
-506,462
| -91% | -$46.6M |
|
613
Sun Communities
SUI
$14B
| $4.97M | 0.01% |
28,344
-11,163
| -28% | -$2.07M |
|
614
iRhythm Holdings
IRTC
$3.69B
| $4.96M | 0.01% |
31,507
| – | – |
|
615
Gentex
GNTX
$4.7B
| $4.96M | 0.01% |
170,082
-62,552
| -27% | -$1.95M |
|
616
AMN Healthcare
AMN
$1.35B
| $4.96M | 0.01% |
47,494
+44,994
| +1,800% | +$4.67M |
|
617
Minerals Technologies
MTX
$2.15B
| $4.94M | 0.01% |
74,700
-3,300
| -4% | -$228K |
|
618
LCI Industries
LCII
$2.12B
| $4.88M | 0.01% |
47,000
-10,322
| -18% | -$1.29M |
|
619
Edison International
EIX
$21.1B
| $4.85M | 0.01% |
69,130
+29,757
| +76% | +$1.9M |
|
620
Ovintiv
OVV
$17.4B
| $4.83M | 0.01% |
89,300
+26,580
| +42% | +$1.15M |
|
|
MRO
621
DELISTED
Marathon Oil Corporation
MRO
| $4.78M | 0.01% |
190,300
+7,900
| +4% | +$170K |
|
|
TPIC
622
DELISTED
TPI Composites
TPIC
| $4.76M | 0.01% |
338,376
-22,073
| -6% | -$281K |
|
623
Ingersoll Rand
IR
$27.7B
| $4.75M | 0.01% |
94,390
+54,221
| +135% | +$2.9M |
|
624
Ambev
ABEV
$46.1B
| $4.73M | 0.01% |
1,464,547
+101,000
| +7% | +$282K |
|
625
FTI Consulting
FCN
$4.01B
| $4.69M | 0.01% |
29,800
-1,600
| -5% | -$239K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.